| 1 | Hallux valgus (acquired) | FING00000601 | 232.28 |
| 2 | Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary Operations | UKBB00000587 | 157.25 |
| 3 | Hip width to body height ratio | GCST90270260 | 143.21 |
| 4 | Abdominal hernia | digestive | UKBB00000002 | 141.64 |
| 5 | Inguinal hernia | FING00000681 | 141.38 |
| 6 | Inguinal hernia | Hernia | UKBB00000363 | 137.14 |
| 7 | Hernia | FING00000616 | 136.35 |
| 8 | Inguinal hernia | digestive | UKBB00000362 | 135.06 |
| 9 | VNN2 levels | GCST90618510 | 127.40 |
| 10 | Gout (PheCode 274.1) | GCST90043662 | 108.63 |
| 11 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 105.01 |
| 12 | Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heel | UKBB00000321 | 100.15 |
| 13 | Hip index | GCST012229 | 98.45 |
| 14 | C21orf58 levels | GCST90618380 | 94.30 |
| 15 | Dupuytren's disease | GCST90301252 | 93.45 |
| 16 | FGR levels | GCST90469236 | 88.71 |
| 17 | HSPG2/IGFBP6 ratio | GCST90315091 | 88.08 |
| 18 | Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heel | UKBB00000323 | 87.86 |
| 19 | Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heel | UKBB00000317 | 87.82 |
| 20 | TNXB levels | GCST90470930 | 87.15 |
| 21 | Heel bone mineral density (BMD) (right) | Bone-densitometry of heel | UKBB00000314 | 86.06 |
| 22 | Abdominal hernia (PheCode 550) | GCST90476059 | 84.33 |
| 23 | CBLN4 levels | GCST90468554 | 84.24 |
| 24 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320887 | 83.05 |
| 25 | Oblique pelvic inlet length | GCST90448909 | 82.39 |
| 26 | Operation code - inguinal/femoral hernia repair | Operations | UKBB00000561 | 82.21 |
| 27 | Subclinical hyperthyroidism in pregnancy | GCST90435199 | 81.61 |
| 28 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 79.14 |
| 29 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 77.66 |
| 30 | Diaphragmatic hernia (PheCode 550.2) | GCST90476061 | 77.37 |
| 31 | ROBO2 levels | GCST90470490 | 76.79 |
| 32 | Bone density (confirmatory factor analysis Factor 19) | GCST90309353 | 76.03 |
| 33 | Alzheimer's disease (MTAG) | GCST90449055 | 75.55 |
| 34 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 75.31 |
| 35 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 74.92 |
| 36 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 74.92 |
| 37 | Central corneal thickness | GCST006366 | 74.05 |
| 38 | Prescriptions - prostaglandin analog | UKBB00000697 | 73.13 |
| 39 | Phenylalanine levels | GCST90243407 | 71.97 |
| 40 | Waist circumference adjusted for body mass index | GCST90020029 | 70.24 |
| 41 | Osteoporosis, osteopenia and pathological fracture (PheCode 743) | GCST90476258 | 69.68 |
| 42 | A body shape index | GCST90020024 | 68.83 |
| 43 | Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heel | UKBB00000318 | 68.47 |
| 44 | Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heel | UKBB00000324 | 68.47 |
| 45 | Autorefraction - 6mm asymmetry index (right) | Eyesight | UKBB00000074 | 67.82 |
| 46 | Heel bone mineral density (BMD) | Bone-densitometry of heel | UKBB00000315 | 67.59 |
| 47 | Carpal tunnel syndrome | FING00000257 | 67.11 |
| 48 | Diaphragmatic hernia | FING00000419 | 66.98 |
| 49 | Iliac isthmus breadth | GCST90448907 | 65.02 |
| 50 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 64.72 |
| 51 | Waist-to-Hip ratio | Body measurement | UKBB00000905 | 63.78 |
| 52 | Pelvic organ prolapse | GCST90102470 | 62.34 |
| 53 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 62.33 |
| 54 | ROBO2/SCARF2 ratio | GCST90315784 | 62.00 |
| 55 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 61.80 |
| 56 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 60.24 |
| 57 | Waist circumference adjusted for body mass index | GCST90302892 | 59.82 |
| 58 | Fracture of forearm | GCST90281273 | 59.81 |
| 59 | Disorders of muscle, ligament, and fascia | musculoskeletal | UKBB00000187 | 58.81 |
| 60 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 58.81 |
| 61 | Waist-hip index | GCST90020027 | 57.99 |
| 62 | IGFBP6/SMOC2 ratio | GCST90315138 | 57.37 |
| 63 | Autorefraction - 6mm weak meridian (left) | Eyesight | UKBB00000079 | 56.58 |
| 64 | Autorefraction - 6mm strong meridian (left) | Eyesight | UKBB00000075 | 56.43 |
| 65 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 56.10 |
| 66 | Waist-hip index | GCST012228 | 56.07 |
| 67 | IDP dMRI TBSS OD Fornix | GCST90004407 | 55.99 |
| 68 | Inguinal hernia (PheCode 550.1) | GCST90476060 | 55.56 |
| 69 | Waist-to-hip ratio adjusted for BMI | GCST012230 | 55.26 |
| 70 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 54.55 |
| 71 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24) | GCST90320587 | 53.94 |
| 72 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 53.47 |
| 73 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 53.14 |
| 74 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 52.88 |
| 75 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 51.68 |
| 76 | Contracture of palmar fascia [Dupuytren's disease] | musculoskeletal | UKBB00000146 | 51.14 |
| 77 | Heel bone mineral density | GCST006288 | 50.57 |
| 78 | Impedance of arm right (UKB data field 23109) | GCST90468172 | 50.52 |
| 79 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 50.45 |
| 80 | Autorefraction - 3mm weak meridian (left) | Eyesight | UKBB00000069 | 49.56 |
| 81 | Ankle spacing width | Bone-densitometry of heel | UKBB00000035 | 48.72 |
| 82 | IDP dMRI ProbtrackX MO str r | GCST90004024 | 48.67 |
| 83 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 48.54 |
| 84 | COL6A3/SMOC2 ratio | GCST90314178 | 48.50 |
| 85 | Autorefraction - 3mm weak meridian (right) | Eyesight | UKBB00000070 | 47.57 |
| 86 | Impedance of arm left (UKB data field 23110) | GCST90468171 | 47.00 |
| 87 | Intestinal infectious diseases | FING00000689 | 46.75 |
| 88 | DTI autoptx FA str r tract | GCST90385136 | 46.63 |
| 89 | Umbilical hernia (PheCode 550.4) | GCST90476062 | 46.57 |
| 90 | CTSD/PRCP ratio | GCST90314312 | 46.54 |
| 91 | Barrett's esophagus (PheCode 530.13) | GCST90476048 | 46.21 |
| 92 | Autorefraction - 6mm strong meridian angle (right) | Eyesight | UKBB00000078 | 46.04 |
| 93 | Lung function (FVC) | GCST007429 | 45.67 |
| 94 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 45.13 |
| 95 | Impedance of arm (right) | Impedance measures | UKBB00000357 | 44.53 |
| 96 | Impedance of arm (left) | Impedance measures | UKBB00000356 | 44.35 |
| 97 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 44.25 |
| 98 | Metabolic disorder, other/unspecified | FING00000815 | 44.23 |
| 99 | Pulse pressure | GCST90301703 | 44.22 |
| 100 | Deforming dorsopathies | FING00000385 | 43.82 |
| 101 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 43.39 |
| 102 | Ventral hernia (PheCode 550.5) | GCST90476063 | 43.21 |
| 103 | Corneal resistance factor | GCST90100568 | 43.05 |
| 104 | Ribothymidine levels in chronic kidney disease | GCST90257554 | 42.96 |
| 105 | BCAN/DPP6 ratio | GCST90313478 | 42.89 |
| 106 | RET levels | GCST90470458 | 42.85 |
| 107 | Autorefraction - 3mm strong meridian (right) | Eyesight | UKBB00000066 | 42.64 |
| 108 | COL6A3/CST3 ratio | GCST90314174 | 42.62 |
| 109 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 42.36 |
| 110 | Kyphosis (MTAG) | GCST90570047 | 42.26 |
| 111 | Autorefraction - 3mm strong meridian (left) | Eyesight | UKBB00000065 | 41.94 |
| 112 | Female genital prolapse | FING00000535 | 41.74 |
| 113 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8 | ECGU000008 | 41.57 |
| 114 | Palmar fascial fibromatosis [Dupuytren] | FING00001141 | 41.36 |
| 115 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4 | ECGU000004 | 41.31 |
| 116 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 40.60 |
| 117 | NCR3 levels | GCST90088179 | 40.46 |
| 118 | Diverticulosis (PheCode 562.1) | GCST90476076 | 40.11 |
| 119 | Fractured/broken bones in last 5 years | Medical conditions | UKBB00000258 | 39.93 |
| 120 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 39.80 |
| 121 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 39.75 |
| 122 | Autorefraction - 6mm weak meridian (right) | Eyesight | UKBB00000080 | 39.73 |
| 123 | Haemorrhoidal disease | GCST90014033 | 39.51 |
| 124 | Pulse pressure | GCST90472785 | 39.26 |
| 125 | Other mental disorders due to brain damage and dysfunction and to physical disease | FING00001072 | 39.15 |
| 126 | Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia | GCST90624744 | 39.04 |
| 127 | Diverticular disease of intestine | Other diseases of intestines | UKBB00000189 | 38.89 |
| 128 | Pelvic inlet width | GCST90448910 | 38.74 |
| 129 | Osteoporosis NOS (PheCode 743.11) | GCST90476260 | 38.63 |
| 130 | Fasciitis | musculoskeletal | UKBB00000239 | 38.62 |
| 131 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 38.46 |
| 132 | BA-exvivo lh area entorhinal | GCST90003220 | 38.35 |
| 133 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 38.29 |
| 134 | Autorefraction - 6mm strong meridian (right) | Eyesight | UKBB00000076 | 38.20 |
| 135 | Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302779 | 37.75 |
| 136 | Diverticulosis and diverticulitis | digestive | UKBB00000191 | 37.65 |
| 137 | aparc-a2009s lh volume S-central | GCST90002969 | 37.64 |
| 138 | Appendicular lean mass | GCST90000027 | 37.58 |
| 139 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 37.05 |
| 140 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 37.04 |
| 141 | Diverticulosis | digestive | UKBB00000190 | 37.02 |
| 142 | ZNRF4 levels | GCST90471104 | 37.01 |
| 143 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 36.61 |
| 144 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 36.57 |
| 145 | EGFR/FAP ratio | GCST90314613 | 36.47 |
| 146 | Scoliosis | FING00001281 | 36.30 |
| 147 | Osteoporosis (PheCode 743.1) | GCST90476259 | 36.07 |
| 148 | Subpubic angle | GCST90448908 | 35.97 |
| 149 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 35.93 |
| 150 | Intraocular pressure | GCST004074 | 35.81 |
| 151 | VCAN levels | GCST90471032 | 35.61 |
| 152 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 35.60 |
| 153 | Femur length to body height ratio | GCST90270256 | 35.48 |
| 154 | 4-hydroxyglutamate levels | GCST90199890 | 35.41 |
| 155 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 35.40 |
| 156 | Appendicular lean mass | GCST90000026 | 35.25 |
| 157 | Impedance of whole body | Impedance measures | UKBB00000360 | 35.24 |
| 158 | Benign neoplasm: Adrenal gland | FING00000164 | 35.20 |
| 159 | Glucose levels | GCST90132724 | 35.11 |
| 160 | BA-exvivo rh volume BA4p | GCST90002854 | 34.81 |
| 161 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 34.77 |
| 162 | Hip circumference adjusted for BMI | GCST012227 | 34.76 |
| 163 | Pulse pressure | GCST90301701 | 34.62 |
| 164 | Acylcarnitine (18:2) levels | GCST90024623 | 34.01 |
| 165 | Waist circumference adjusted for body mass index | GCST012226 | 33.95 |
| 166 | Primary open-angle glaucoma, strict | FING00001214 | 33.74 |
| 167 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 33.57 |
| 168 | Fracture of forearm | FING00000554 | 33.51 |
| 169 | CD200R1 levels | GCST90468605 | 33.47 |
| 170 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 33.46 |
| 171 | aparc-pial rh area inferiorparietal | GCST90003181 | 33.41 |
| 172 | Fractures | GCST006980 | 33.34 |
| 173 | aparc-a2009s rh area S-collat-transv-ant | GCST90003420 | 33.25 |
| 174 | Pelvic height | GCST90448912 | 33.04 |
| 175 | Progressive vascular leukoencephalopathy | FING00001218 | 32.90 |
| 176 | EIF4G1/TBC1D23 ratio | GCST90314639 | 32.87 |
| 177 | aparc-a2009s rh volume S-central | GCST90003043 | 32.53 |
| 178 | Glaucoma (primary open-angle) | GCST90011768 | 32.48 |
| 179 | Female genital prolapse | Noninflammatory disorders of female genital tract | UKBB00000244 | 32.11 |
| 180 | Hand grip strength right (UKB data field 47) | GCST90468169 | 32.07 |
| 181 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 32.03 |
| 182 | Height | GCST90018739 | 32.03 |
| 183 | Height (maximum, inv-normal transformed) | GCST90475359 | 31.87 |
| 184 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2 | ECGU000002 | 31.79 |
| 185 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 31.71 |
| 186 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 31.64 |
| 187 | height (mean, inv-normal transformed) | GCST90475362 | 31.62 |
| 188 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126) | GCST90320689 | 31.60 |
| 189 | Glaucoma | GCST90475869 | 31.46 |
| 190 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 31.31 |
| 191 | Appendicular lean mass | GCST90000025 | 31.30 |
| 192 | Umbilical hernia | Hernia | UKBB00000881 | 30.89 |
| 193 | Forearm length to body height ratio | GCST90270257 | 30.88 |
| 194 | Impedance of leg (left) | Impedance measures | UKBB00000358 | 30.80 |
| 195 | Autorefraction - 6mm asymmetry index (left) | Eyesight | UKBB00000073 | 30.66 |
| 196 | PSPN levels | GCST90470364 | 30.58 |
| 197 | Hip index | GCST90020026 | 30.48 |
| 198 | Sitting height | Body size measures | UKBB00000771 | 30.43 |
| 199 | height (minimum, inv-normal transformed) | GCST90475365 | 30.31 |
| 200 | BA-exvivo lh volume BA3a | GCST90002837 | 30.15 |
| 201 | Waist-to-hip ratio adjusted for BMI | GCST90025996 | 30.13 |
| 202 | Umbilical hernia | digestive | UKBB00000880 | 30.06 |
| 203 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 30.06 |
| 204 | COL4A1 levels | GCST90468818 | 30.04 |
| 205 | wg rh intensity-contrast parahippocampal | GCST90003842 | 30.01 |
| 206 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | GCST90320654 | 29.94 |
| 207 | Glaucoma | GCST90018632 | 29.91 |
| 208 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 29.91 |
| 209 | BA-exvivo rh volume BA3a | GCST90002851 | 29.72 |
| 210 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 29.72 |
| 211 | BA-exvivo lh volume entorhinal | GCST90002848 | 29.56 |
| 212 | Volume of right basal nucleus | GCST90475012 | 29.45 |
| 213 | C7 levels | GCST90422332 | 29.35 |
| 214 | DPP6/SEZ6L2 ratio | GCST90314543 | 29.21 |
| 215 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 29.19 |
| 216 | Pulse pressure | GCST90301702 | 28.99 |
| 217 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 28.98 |
| 218 | IDP dMRI TBSS MO Fornix | GCST90003957 | 28.93 |
| 219 | Osteoporosis | musculoskeletal | UKBB00000598 | 28.85 |
| 220 | Corneal resistance factor | GCST90308682 | 28.82 |
| 221 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320883 | 28.70 |
| 222 | Impedance of leg (right) | Impedance measures | UKBB00000359 | 28.66 |
| 223 | Height | GCST90278637 | 28.47 |
| 224 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 28.31 |
| 225 | Tibia length to body height ratio | GCST90270258 | 28.22 |
| 226 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 28.15 |
| 227 | Prescriptions - anti-malarial | UKBB00000663 | 28.14 |
| 228 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 28.14 |
| 229 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 28.11 |
| 230 | DPP4/ITGB1 ratio | GCST90314540 | 28.08 |
| 231 | RFC4 levels | GCST90470460 | 28.03 |
| 232 | LGALS3 levels | GCST90469761 | 27.99 |
| 233 | AOC3 levels | GCST90468322 | 27.94 |
| 234 | Height | GCST90302890 | 27.87 |
| 235 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110) | GCST90320929 | 27.86 |
| 236 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 27.71 |
| 237 | QC T1 inverse SNR | GCST90006348 | 27.71 |
| 238 | Diaphragmatic hernia | digestive | UKBB00000171 | 27.54 |
| 239 | Anterior thigh muscle volume | GCST90267349 | 27.42 |
| 240 | Pelvic width | GCST90448911 | 27.37 |
| 241 | Seated height | Body size measures | UKBB00000763 | 27.33 |
| 242 | Glaucoma suspect | FING00000579 | 27.32 |
| 243 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1 | ECGU000001 | 27.30 |
| 244 | FAP levels | GCST90469189 | 27.25 |
| 245 | Standing height | Body size measures | UKBB00000796 | 27.14 |
| 246 | DTI autoptx L3 str r tract | GCST90385217 | 26.82 |
| 247 | Heart rate variability traits (SDNN) | GCST004734 | 26.82 |
| 248 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 26.51 |
| 249 | Autorefraction - 3mm strong meridian angle (left) | Eyesight | UKBB00000067 | 26.50 |
| 250 | SLITRK6 levels | GCST90470671 | 26.34 |
| 251 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 26.32 |
| 252 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10 | ECGU000010 | 26.30 |
| 253 | Operation code - inguinal hernia repair | Operations | UKBB00000560 | 26.26 |
| 254 | Other joint disorders | FING00001064 | 26.24 |
| 255 | CDON/SCARA5 ratio | GCST90313995 | 26.23 |
| 256 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 26.23 |
| 257 | HSPG2/SMOC2 ratio | GCST90315093 | 26.21 |
| 258 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 26.15 |
| 259 | Hammer toe (acquired) (PheCode 735.21) | GCST90476250 | 25.94 |
| 260 | Prolapse of vaginal walls | genitourinary | UKBB00000712 | 25.87 |
| 261 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 25.65 |
| 262 | Diarrhoea and gastroenteritis of presumed infectious origin | FING00000420 | 25.63 |
| 263 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320860 | 25.61 |
| 264 | Glaucoma (multi-trait analysis) | GCST009722 | 25.50 |
| 265 | EFEMP1/TGFBR3 ratio | GCST90314597 | 25.39 |
| 266 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 25.38 |
| 267 | HHIP levels | GCST90617097 | 25.33 |
| 268 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 25.33 |
| 269 | IDP dMRI TBSS MD External capsule L | GCST90004060 | 25.24 |
| 270 | CD164/PARK7 ratio | GCST90313743 | 25.18 |
| 271 | Spondylolisthesis/Spondylolysis | FING00001324 | 25.17 |
| 272 | Autorefraction - 3mm cylindrical power (left) | Eyesight | UKBB00000062 | 25.12 |
| 273 | CLMP/PIK3IP1 ratio | GCST90314134 | 25.11 |
| 274 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77) | GCST90320896 | 25.10 |
| 275 | Comparative height size at age 10 | Early life factors | UKBB00000143 | 25.08 |
| 276 | BOC levels | GCST90468458 | 24.54 |
| 277 | HSPG2 levels | GCST90179392 | 24.21 |
| 278 | PILRA/TNFRSF1A ratio | GCST90315655 | 24.18 |
| 279 | ENG levels | GCST90469108 | 24.10 |
| 280 | PECAM1/SOD2 ratio | GCST90315647 | 24.03 |
| 281 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000715 | 23.99 |
| 282 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 23.92 |
| 283 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 23.92 |
| 284 | IDP dMRI ProbtrackX L1 ptr l | GCST90004265 | 23.85 |
| 285 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 23.79 |
| 286 | Hand grip strength (right) | Hand grip strength | UKBB00000301 | 23.77 |
| 287 | IDP dMRI TBSS L2 Sagittal stratum L | GCST90004154 | 23.74 |
| 288 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115) | GCST90320678 | 23.68 |
| 289 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 23.64 |
| 290 | CD34 levels | GCST90468626 | 23.59 |
| 291 | OLR1 levels | GCST90012020 | 23.59 |
| 292 | Descending aorta diameter | GCST90267391 | 23.57 |
| 293 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 23.51 |
| 294 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75) | GCST90320894 | 23.51 |
| 295 | Glaucoma (primary open-angle) | GCST90399725 | 23.48 |
| 296 | ITGAM/ITGAV ratio | GCST90315209 | 23.41 |
| 297 | CTSO/IGF2R ratio | GCST90314317 | 23.39 |
| 298 | Fracture at wrist and hand level | FING00000551 | 23.37 |
| 299 | Body size (confirmatory factor analysis Factor 21) | GCST90309355 | 23.35 |
| 300 | Trunk fat percentage | Impedance measures | UKBB00000864 | 23.32 |
| 301 | A body shape index | GCST012231 | 23.29 |
| 302 | Inguinal hernia, bilateral | FING00000682 | 23.20 |
| 303 | CNTN1 levels | GCST90468803 | 23.19 |
| 304 | CDON levels | GCST90468687 | 23.11 |
| 305 | Age-related eyesight deterioration (confirmatory factor analysis Factor 27) | GCST90309361 | 23.09 |
| 306 | FNDC1 levels | GCST90469256 | 23.08 |
| 307 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000719 | 22.91 |
| 308 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 22.90 |
| 309 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 22.88 |
| 310 | COL6A3/COLEC12 ratio | GCST90314173 | 22.85 |
| 311 | LTBP2 levels | GCST90469814 | 22.78 |
| 312 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007526 | 22.77 |
| 313 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 22.73 |
| 314 | Standing height (UKB data field 50) | GCST90468178 | 22.73 |
| 315 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 22.72 |
| 316 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 22.69 |
| 317 | Genital prolapse | genitourinary | UKBB00000282 | 22.68 |
| 318 | Use of antiglaucoma preparations and miotics | FING00001409 | 22.50 |
| 319 | PSAP levels | GCST90426586 | 22.39 |
| 320 | O-sulfo-l-tyrosine levels | GCST90243623 | 22.26 |
| 321 | MATN2 levels | GCST90469864 | 22.24 |
| 322 | SMOC2 levels | GCST90470683 | 21.98 |
| 323 | Pulse pressure | GCST90472783 | 21.92 |
| 324 | Bone density T-score | GCST90278620 | 21.91 |
| 325 | CPM levels | GCST90240598 | 21.91 |
| 326 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37) | GCST90320856 | 21.86 |
| 327 | IDP dMRI TBSS L2 Posterior limb of internal capsule R | GCST90004141 | 21.85 |
| 328 | PSG1 levels | GCST90470353 | 21.80 |
| 329 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 21.79 |
| 330 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 21.68 |
| 331 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 21.64 |
| 332 | Hand grip strength left (UKB data field 46) | GCST90468168 | 21.56 |
| 333 | DTI TBSS L1 Fornix | GCST90384433 | 21.53 |
| 334 | Hip circumference adjusted for BMI | GCST90020028 | 21.50 |
| 335 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | GCST90320903 | 21.48 |
| 336 | aparc-a2009s lh volume G-precentral | GCST90002953 | 21.48 |
| 337 | aparc-pial rh area parstriangularis | GCST90003193 | 21.39 |
| 338 | wg lh intensity-contrast transversetemporal | GCST90003825 | 21.36 |
| 339 | DLK1/FAP ratio | GCST90314491 | 21.32 |
| 340 | Left-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302682 | 21.28 |
| 341 | TNC levels | GCST90470895 | 21.16 |
| 342 | Fibroblastic disorders | FING00000542 | 21.07 |
| 343 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 21.01 |
| 344 | ADAMTSL2 levels | GCST90468228 | 21.01 |
| 345 | Blepharochalasis | FING00000220 | 21.00 |
| 346 | Pulse pressure | GCST90310296 | 20.86 |
| 347 | Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000445 | 20.84 |
| 348 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123) | GCST90320686 | 20.66 |
| 349 | Ankle spacing width (right) | Bone-densitometry of heel | UKBB00000034 | 20.63 |
| 350 | Acquired foot deformities | musculoskeletal | UKBB00000007 | 20.58 |
| 351 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114) | GCST90320677 | 20.54 |
| 352 | DLK1/PIK3IP1 ratio | GCST90314492 | 20.54 |
| 353 | IDP dMRI TBSS L2 Fornix | GCST90004128 | 20.44 |
| 354 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98) | GCST90320661 | 20.41 |
| 355 | Height (baseline) | GCST90565843 | 20.39 |
| 356 | IDP dMRI TBSS ICVF Fornix | GCST90004332 | 20.38 |
| 357 | IDP T1 FAST ROIs L caudate | GCST90002549 | 20.37 |
| 358 | Diaphragmatic hernia | Hernia | UKBB00000172 | 20.36 |
| 359 | Coronary artery calcification | GCST90278456 | 20.33 |
| 360 | EGFR levels | GCST90469085 | 20.27 |
| 361 | SCARA5 levels | GCST90470533 | 20.23 |
| 362 | CD79B/FCRL2 ratio | GCST90313900 | 20.21 |
| 363 | Bone density Z-score | GCST90278621 | 20.21 |
| 364 | Volume of right accessory basal nucleus | GCST90475006 | 20.07 |
| 365 | BCL2 levels | GCST90468433 | 20.00 |
| 366 | Volume of left basal nucleus | GCST90474946 | 19.94 |
| 367 | ADGRD1 levels | GCST90468235 | 19.88 |
| 368 | F7/VASN ratio | GCST90314745 | 19.83 |
| 369 | Height (standard GWA) | GCST90267284 | 19.81 |
| 370 | Pain type(s) experienced in last month - Back pain | Pain | UKBB00000626 | 19.74 |
| 371 | AHCY/HSPA1A ratio | GCST90313211 | 19.74 |
| 372 | Aortic aneurysm (PheCode 442.1) | GCST90475993 | 19.65 |
| 373 | Hydrocele | FING00000627 | 19.63 |
| 374 | Operative procedures - Angiocardiography of left side of heart NEC | Summary Operations | UKBB00000572 | 19.56 |
| 375 | Mean volume of bilateral amygdala | GCST90474994 | 19.53 |
| 376 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107) | GCST90320670 | 19.53 |
| 377 | Incisional hernia (PheCode 550.6) | GCST90476064 | 19.43 |
| 378 | CCN3/FAP ratio | GCST90313721 | 19.36 |
| 379 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 19.31 |
| 380 | IDP dMRI TBSS MD Fornix | GCST90004032 | 19.31 |
| 381 | FAP/LRRN1 ratio | GCST90314783 | 19.28 |
| 382 | DAB2/TBL1X ratio | GCST90314368 | 19.27 |
| 383 | Phenylacetylcarnitine levels | GCST90199993 | 19.19 |
| 384 | SFRP2 levels | GCST90242727 | 19.18 |
| 385 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 19.15 |
| 386 | DPP6/SEZ6L ratio | GCST90314544 | 19.12 |
| 387 | Diastolic blood pressure x sex interaction | GCST90335175 | 19.07 |
| 388 | CA2/HMBS ratio | GCST90313579 | 18.96 |
| 389 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 18.93 |
| 390 | PLXDC1 levels | GCST90470263 | 18.90 |
| 391 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 18.83 |
| 392 | wg rh intensity-contrast caudalmiddlefrontal | GCST90003830 | 18.75 |
| 393 | FST/FSTL3 ratio | GCST90314882 | 18.72 |
| 394 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 18.68 |
| 395 | ADGRB3 levels | GCST90468234 | 18.66 |
| 396 | ISLR2 levels | GCST90469629 | 18.64 |
| 397 | CD109 levels | GCST90468597 | 18.63 |
| 398 | Endometriosis of ovary | FING00000501 | 18.63 |
| 399 | FCRL2/TNFRSF13B ratio | GCST90314801 | 18.62 |
| 400 | Knee extension strength | GCST90319502 | 18.48 |
| 401 | ESR1 levels | GCST90469155 | 18.43 |
| 402 | Height, inverse-rank normalized | FING00000607 | 18.37 |
| 403 | RGMB/SMOC2 ratio | GCST90315770 | 18.35 |
| 404 | Mononeuropathies of upper limb | Nerve, nerve root and plexus disorders | UKBB00000481 | 18.34 |
| 405 | BA-exvivo lh volume BA4p | GCST90002840 | 18.26 |
| 406 | Volume of left paralaminar nucleus | GCST90474982 | 18.26 |
| 407 | PLXDC2 levels | GCST90470264 | 18.01 |
| 408 | Polyp of the female genital tract | FING00001190 | 17.96 |
| 409 | APOF levels | GCST90468339 | 17.96 |
| 410 | IDP dMRI TBSS MD Pontine crossing tract | GCST90004028 | 17.89 |
| 411 | Other intervertebral disc disorders | FING00001063 | 17.84 |
| 412 | BTN2A1/SMOC2 ratio | GCST90313549 | 17.82 |
| 413 | PAMR1 levels | GCST90470155 | 17.79 |
| 414 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 17.78 |
| 415 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 17.69 |
| 416 | Nerve, nerve root and plexus disorders | FING00000862 | 17.62 |
| 417 | ADAMTS8 levels | GCST90468227 | 17.54 |
| 418 | COMP/DPP4 ratio | GCST90314188 | 17.53 |
| 419 | aparc-Desikan lh volume precentral | GCST90002791 | 17.50 |
| 420 | Early lumbar disc prolapse, operated | FING00000484 | 17.47 |
| 421 | Volume of right paralaminar nucleus | GCST90475048 | 17.36 |
| 422 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320944 | 17.26 |
| 423 | BA-exvivo rh volume BA45 | GCST90002857 | 17.24 |
| 424 | ATXN2L levels | GCST90468402 | 17.14 |
| 425 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 17.14 |
| 426 | UNC5D levels | GCST90471010 | 17.11 |
| 427 | Left hippocampal volume (tail) | GCST90267951 | 17.10 |
| 428 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 17.05 |
| 429 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000717 | 17.04 |
| 430 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 17.02 |
| 431 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 16.98 |
| 432 | ALKBH3 levels | GCST90619095 | 16.87 |
| 433 | REST UKBBICA NET100 1287 | GCST90387141 | 16.77 |
| 434 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 16.76 |
| 435 | MAMDC2 levels | GCST90469841 | 16.75 |
| 436 | IDP dMRI TBSS L3 External capsule L | GCST90004204 | 16.73 |
| 437 | IFIT2 levels | GCST90090864 | 16.71 |
| 438 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 16.65 |
| 439 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58) | GCST90320621 | 16.64 |
| 440 | CNTN5 levels | GCST90468807 | 16.58 |
| 441 | Other aneurysm (PheCode 442) | GCST90475992 | 16.58 |
| 442 | Pneumonia | GCST90018681 | 16.56 |
| 443 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320895 | 16.54 |
| 444 | Heart rate variability (corrected standard deviation of normal-to-normal intervals) | GCST90281266 | 16.50 |
| 445 | Metabolonic lactone sulfate levels | GCST90200257 | 16.48 |
| 446 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 16.47 |
| 447 | Takes medication for Macular Degeneration? | GCST90475387 | 16.44 |
| 448 | QC dMRI-to-T1 linear alignment discrepancy | GCST90006351 | 16.41 |
| 449 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 16.39 |
| 450 | COMP/MYOC ratio | GCST90314191 | 16.36 |
| 451 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000721 | 16.32 |
| 452 | SNX9/STIP1 ratio | GCST90315864 | 16.32 |
| 453 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 89) | GCST90320652 | 16.29 |
| 454 | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302715 | 16.27 |
| 455 | FGF19 levels | GCST90469220 | 16.23 |
| 456 | Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763) | GCST90476268 | 16.17 |
| 457 | FOLH1 levels | GCST90427192 | 16.15 |
| 458 | ASPN levels | GCST90468377 | 16.14 |
| 459 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000716 | 16.08 |
| 460 | Macular degeneration | GCST90475386 | 16.07 |
| 461 | Myopia (PheCode 367.1) | GCST90475880 | 16.04 |
| 462 | RBP7 levels | GCST90470440 | 16.03 |
| 463 | HSPG2/VASN ratio | GCST90315094 | 16.00 |
| 464 | IDP dMRI ProbtrackX FA ilf l | GCST90003939 | 15.97 |
| 465 | BSG/LAMP3 ratio | GCST90313533 | 15.94 |
| 466 | End-diastolic bi-ventricular shape (principal component 4) | GCST90448483 | 15.93 |
| 467 | Hallux valgus (Bunion) | musculoskeletal | UKBB00000299 | 15.92 |
| 468 | BA-exvivo lh volume BA6 | GCST90002841 | 15.91 |
| 469 | MYOC levels | GCST90469983 | 15.84 |
| 470 | Retinal breaks without detachment | FING00001258 | 15.84 |
| 471 | CHRDL1/SMOC2 ratio | GCST90314062 | 15.82 |
| 472 | Sleep apnea (MTAG) (adjusted for BMI) | GCST90267364 | 15.79 |
| 473 | QC tfMRI-to-T1 linear alignment discrepancy | GCST90006354 | 15.76 |
| 474 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 15.70 |
| 475 | PRTG levels | GCST90470347 | 15.64 |
| 476 | IDP dMRI ProbtrackX MD ar l | GCST90004219 | 15.64 |
| 477 | ADGRG2 levels | GCST90468241 | 15.59 |
| 478 | Primary open angle glaucoma (PheCode 365.11) | GCST90475875 | 15.58 |
| 479 | Age-related macular degeneration | GCST90086111 | 15.58 |
| 480 | PPP2R2A levels | GCST90618122 | 15.52 |
| 481 | COL6A3/HSPG2 ratio | GCST90314175 | 15.51 |
| 482 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 15.45 |
| 483 | aseg global volume EstimatedTotalIntraCranial | GCST90002597 | 15.44 |
| 484 | Shoulder width to body height ratio | GCST90270261 | 15.42 |
| 485 | diastolic blood pressure (DBP, mean, inv-normal transformed) | GCST90475255 | 15.39 |
| 486 | wg lh intensity-contrast middletemporal | GCST90003806 | 15.37 |
| 487 | THBS2 levels | GCST90470854 | 15.34 |
| 488 | GRAP2/SNX9 ratio | GCST90314988 | 15.34 |
| 489 | Keloid | GCST90652488 | 15.32 |
| 490 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103) | GCST90320922 | 15.29 |
| 491 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 15.27 |
| 492 | Glaucoma | FING00000577 | 15.26 |
| 493 | IDP dMRI ProbtrackX FA str l | GCST90003948 | 15.25 |
| 494 | Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivity | GCST90302653 | 15.25 |
| 495 | Frequency of light DIY in last 4 weeks | Physical activity | UKBB00000264 | 15.20 |
| 496 | BA-exvivo rh area perirhinal | GCST90003233 | 15.19 |
| 497 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 15.18 |
| 498 | Ankle spacing width (left) | Bone-densitometry of heel | UKBB00000033 | 15.16 |
| 499 | IDP dMRI TBSS FA Tapetum L | GCST90003924 | 14.93 |
| 500 | Hypertrophy of breast | FING00000644 | 14.89 |
| 501 | IDP dMRI TBSS FA Fornix | GCST90003882 | 14.87 |
| 502 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T11 | ECGU000011 | 14.86 |
| 503 | IDP dMRI TBSS L1 Fornix | GCST90004080 | 14.83 |
| 504 | Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000428 | 14.82 |
| 505 | SFRP4 levels | GCST90470611 | 14.81 |
| 506 | Volume of right lateral nucleus | GCST90475034 | 14.77 |
| 507 | Abdominal aortic aneurysm (PheCode 442.11) | GCST90475994 | 14.76 |
| 508 | aparc-DKTatlas lh volume precentral | GCST90002884 | 14.76 |
| 509 | ENPP7 levels | GCST90469118 | 14.73 |
| 510 | 10-undecenoate (11:1n1) levels | GCST90243596 | 14.73 |
| 511 | PRELP levels | GCST90470321 | 14.72 |
| 512 | INHBC levels | GCST90469615 | 14.70 |
| 513 | IDP dMRI TBSS L3 Uncinate fasciculus R | GCST90004215 | 14.69 |
| 514 | CCN3 levels | GCST90468589 | 14.59 |
| 515 | EFNA1/PIK3IP1 ratio | GCST90314598 | 14.58 |
| 516 | Volume of right cortico-amygdaloid transition area | GCST90475018 | 14.55 |
| 517 | Depression/anxiety (weighted GWA) | GCST90267277 | 14.52 |
| 518 | Maximum indexed left atrial volume | GCST90019012 | 14.52 |
| 519 | DTI autoptx L3 unc l tract | GCST90385218 | 14.48 |
| 520 | FURIN/PLA2G15 ratio | GCST90314887 | 14.48 |
| 521 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 14.48 |
| 522 | CALCA levels | GCST90468528 | 14.48 |
| 523 | FGF19/SCG2 ratio | GCST90314809 | 14.43 |
| 524 | Liver proton density fat fraction | GCST90267352 | 14.38 |
| 525 | Levulinate 4-oxovalerate levels | GCST90243545 | 14.36 |
| 526 | Takes medication for Glaucoma? | GCST90475384 | 14.35 |
| 527 | BPIFB1/GLRX ratio | GCST90313530 | 14.32 |
| 528 | Hand grip strength (left) | Hand grip strength | UKBB00000300 | 14.29 |
| 529 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320845 | 14.27 |
| 530 | Volume of right whole amygdala | GCST90475054 | 14.27 |
| 531 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 94) | GCST90320913 | 14.26 |
| 532 | DTI TBSS L1 External capsule R | GCST90384460 | 14.22 |
| 533 | FAM3B/FGF19 ratio | GCST90314776 | 14.22 |
| 534 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8) | GCST90320827 | 14.18 |
| 535 | ICD10 N81: Female genital prolapse | GCST90454214 | 14.16 |
| 536 | CD8 on Effector Memory CD8+ T cell | GCST90002056 | 14.15 |
| 537 | Endometriosis | FING00000497 | 14.14 |
| 538 | HAMP levels | GCST90451683 | 14.11 |
| 539 | DTI TBSS MD Fornix | GCST90384577 | 14.08 |
| 540 | Operative procedures - Carpal tunnel release | Summary Operations | UKBB00000574 | 14.08 |
| 541 | BA-exvivo rh volume BA6 | GCST90002855 | 14.07 |
| 542 | SIL1 levels | GCST90470638 | 14.04 |
| 543 | LILRB4 levels | GCST90426708 | 13.99 |
| 544 | CREG1/NAAA ratio | GCST90314250 | 13.93 |
| 545 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T12 | ECGU000012 | 13.93 |
| 546 | LAMP1 levels | GCST90469733 | 13.91 |
| 547 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 13.89 |
| 548 | Pulse pressure | GCST90472784 | 13.88 |
| 549 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 13.88 |
| 550 | Retinal detachments and defects | sense organs | UKBB00000756 | 13.82 |
| 551 | AIFM1/EGF ratio | GCST90313219 | 13.81 |
| 552 | DLK1 levels | GCST90469003 | 13.74 |
| 553 | Treatment speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000835 | 13.74 |
| 554 | TMSB10/ZBTB16 ratio | GCST90315926 | 13.73 |
| 555 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus L | GCST90004445 | 13.72 |
| 556 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 13.68 |
| 557 | Arthropathies | FING00000107 | 13.67 |
| 558 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 13.66 |
| 559 | Acquired deformities of fingers and toes | Other joint disorders | UKBB00000006 | 13.61 |
| 560 | Peritonsillar abscess | FING00001160 | 13.59 |
| 561 | F7/PROC ratio | GCST90314744 | 13.57 |
| 562 | ThalamNuclei rh volume CeM | GCST90002751 | 13.56 |
| 563 | IDP T1 FAST ROIs R caudate | GCST90002550 | 13.55 |
| 564 | Pregnenediol disulfate (C21H34O8S2) levels | GCST90199840 | 13.53 |
| 565 | SNX5 levels | GCST90470702 | 13.53 |
| 566 | NRP1 levels | GCST90470085 | 13.51 |
| 567 | COL24A1 levels | GCST90468814 | 13.42 |
| 568 | aparc-a2009s rh volume S-orbital-H-Shaped | GCST90003062 | 13.40 |
| 569 | IL31RA levels | GCST90469589 | 13.35 |
| 570 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 13.35 |
| 571 | CASP1 levels | GCST90468543 | 13.34 |
| 572 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 13.31 |
| 573 | Other hammer toe(s) (acquired) | FING00001054 | 13.30 |
| 574 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 13.28 |
| 575 | FST levels | GCST90469273 | 13.26 |
| 576 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 13.24 |
| 577 | Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000477 | 13.23 |
| 578 | DTI autoptx L2 str r tract | GCST90385190 | 13.22 |
| 579 | BA-exvivo rh volume BA1 | GCST90002849 | 13.21 |
| 580 | GLA levels | GCST90469354 | 13.16 |
| 581 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13 | ECGU000013 | 13.14 |
| 582 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 13.08 |
| 583 | IDP dMRI TBSS L3 External capsule R | GCST90004203 | 13.06 |
| 584 | Glaucoma | GCST90468129 | 13.05 |
| 585 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32) | GCST90320595 | 13.05 |
| 586 | Spinal stenosis (PheCode 720) | GCST90476233 | 13.03 |
| 587 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 13.01 |
| 588 | Pregnenetriol disulfate levels | GCST90200238 | 12.99 |
| 589 | Serine levels | GCST90200415 | 12.91 |
| 590 | aparc-DKTatlas rh area parstriangularis | GCST90003283 | 12.84 |
| 591 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106) | GCST90320925 | 12.81 |
| 592 | Humerus length to body height ratio | GCST90270259 | 12.79 |
| 593 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 12.78 |
| 594 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 12.76 |
| 595 | Other disorders of testis (PheCode 603) | GCST90476156 | 12.74 |
| 596 | Left ventricular wall thickness (maximal) | GCST90435263 | 12.73 |
| 597 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320876 | 12.68 |
| 598 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 12.68 |
| 599 | Glaucoma | GCST90475383 | 12.63 |
| 600 | SRPX levels | GCST90470744 | 12.62 |
| 601 | Osteoarthrosis | musculoskeletal | UKBB00000596 | 12.61 |
| 602 | MSMB levels | GCST90469949 | 12.59 |
| 603 | DPP4 levels | GCST90469033 | 12.58 |
| 604 | Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARB | UKBB00000662 | 12.57 |
| 605 | rfMRI amplitudes (ICA100 node 27) | GCST90004615 | 12.54 |
| 606 | Noninflammatory disorders of female genital tract | FING00000882 | 12.52 |
| 607 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 12.47 |
| 608 | Spinal stenosis | FING00001322 | 12.46 |
| 609 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320660 | 12.46 |
| 610 | IDP dMRI TBSS L1 External capsule L | GCST90004108 | 12.46 |
| 611 | CNTN4 levels | GCST90468806 | 12.45 |
| 612 | IDP dMRI TBSS FA Posterior limb of internal capsule R | GCST90003895 | 12.37 |
| 613 | Pulse pressure (BMI adjusted) | GCST90335167 | 12.37 |
| 614 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 12.34 |
| 615 | Benign mammary dysplasia | FING00000151 | 12.33 |
| 616 | COL6A3/OGN ratio | GCST90314177 | 12.33 |
| 617 | FURIN/IGSF3 ratio | GCST90314885 | 12.32 |
| 618 | wg lh intensity-contrast entorhinal | GCST90003797 | 12.22 |
| 619 | Physical function (baseline) | GCST90565837 | 12.20 |
| 620 | Unspecified osteomyelitis (PheCode 710.19) | GCST90476224 | 12.16 |
| 621 | Ventral hernia | FING00001428 | 12.15 |
| 622 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14 | ECGU000014 | 12.13 |
| 623 | Autorefraction - 3mm strong meridian angle (right) | Eyesight | UKBB00000068 | 12.11 |
| 624 | IDP dMRI TBSS OD Superior corona radiata R | GCST90004426 | 12.09 |
| 625 | CD40LG/SERPINE1 ratio | GCST90313826 | 12.03 |
| 626 | IDP dMRI TBSS MD Retrolenticular part of internal capsule L | GCST90004048 | 12.02 |
| 627 | Other headache syndromes | FING00001055 | 12.00 |
| 628 | aparc-a2009s lh area S-collat-transv-ant | GCST90003346 | 12.00 |
| 629 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 11.96 |
| 630 | MFAP4 levels | GCST90469898 | 11.88 |
| 631 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 11.86 |
| 632 | Polyarthrosis | FING00001181 | 11.79 |
| 633 | T1 FreeSurfer aseg 3rd-Ventricle | GCST90384147 | 11.79 |
| 634 | aseg global volume WM-hypointensities | GCST90002604 | 11.74 |
| 635 | CST3/TFF3 ratio | GCST90314299 | 11.74 |
| 636 | IL13RA1 levels | GCST90469552 | 11.68 |
| 637 | Aortic aneurysm | FING00000102 | 11.68 |
| 638 | Illnesses of siblings - Heart disease | Family history | UKBB00000351 | 11.68 |
| 639 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 11.67 |
| 640 | GGH/INHBC ratio | GCST90314928 | 11.64 |
| 641 | ST6GALNAC2 levels | GCST90240251 | 11.63 |
| 642 | Hand grip strength (baseline) | GCST90565845 | 11.62 |
| 643 | DTI TBSS MO Middle cerebellar peduncle | GCST90384620 | 11.61 |
| 644 | PRKAR1A/SNAP23 ratio | GCST90315728 | 11.59 |
| 645 | CPQ levels | GCST90468846 | 11.54 |
| 646 | IDP dMRI ProbtrackX MO str l | GCST90004023 | 11.45 |
| 647 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320681 | 11.45 |
| 648 | Angina | GCST90468109 | 11.43 |
| 649 | Pulse pressure (BMI unadjusted) | GCST90335166 | 11.42 |
| 650 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320688 | 11.41 |
| 651 | Glaucoma | sense organs | UKBB00000287 | 11.41 |
| 652 | CXCL10/WARS ratio | GCST90314332 | 11.34 |
| 653 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 11.28 |
| 654 | Illnesses of father - None of the above (group 1) | Family history | UKBB00000345 | 11.28 |
| 655 | Torso length to body height ratio | GCST90270262 | 11.28 |
| 656 | N-acetylalanine levels | GCST90200303 | 11.27 |
| 657 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93) | GCST90320912 | 11.26 |
| 658 | Thoracic aortic aneurysm | FING00001357 | 11.22 |
| 659 | Kidney transplant status | FING00000710 | 11.21 |
| 660 | CCL8 levels | GCST90422346 | 11.21 |
| 661 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 11.20 |
| 662 | Glaucoma, exfoliation | FING00000580 | 11.20 |
| 663 | ADGRE2/B4GALT1 ratio | GCST90313174 | 11.20 |
| 664 | AARSD1/UBAC1 ratio | GCST90313135 | 11.19 |
| 665 | wg rh intensity-contrast temporalpole | GCST90003859 | 11.18 |
| 666 | IGFBP6/PTGDS ratio | GCST90315137 | 11.15 |
| 667 | IDP dMRI ProbtrackX L2 unc l | GCST90004298 | 11.15 |
| 668 | IDP T1 FAST ROIs V cerebellum VIIIa | GCST90002579 | 11.13 |
| 669 | FUT8/TNFSF14 ratio | GCST90314895 | 11.13 |
| 670 | Calcific aortic valve stenosis | GCST90310293 | 11.10 |
| 671 | wg rh intensity-contrast parstriangularis | GCST90003846 | 11.08 |
| 672 | Hair/balding pattern: Pattern 4 (UKB data field 2395_4) | GCST90043619 | 11.08 |
| 673 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 11.07 |
| 674 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 11.01 |
| 675 | ITGAV levels | GCST90469639 | 11.01 |
| 676 | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | GCST90003972 | 10.99 |
| 677 | Disorders of choroid and retina | FING00000438 | 10.96 |
| 678 | aparc-DKTatlas rh volume precentral | GCST90002915 | 10.96 |
| 679 | CTSZ/NAAA ratio | GCST90314320 | 10.96 |
| 680 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 10.93 |
| 681 | FAP/THBS4 ratio | GCST90314785 | 10.91 |
| 682 | DSG4 levels | GCST90469044 | 10.88 |
| 683 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 10.85 |
| 684 | IDP dMRI ProbtrackX L2 unc r | GCST90004299 | 10.83 |
| 685 | CD27/FCRL5 ratio | GCST90313772 | 10.83 |
| 686 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90024193 | 10.83 |
| 687 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T33 | ECGA000033 | 10.82 |
| 688 | NAAA/SMPD1 ratio | GCST90315510 | 10.81 |
| 689 | IDP dMRI TBSS MD External capsule R | GCST90004059 | 10.81 |
| 690 | X-17676 levels | GCST90200548 | 10.81 |
| 691 | Inguinal hernia | GCST90018648 | 10.81 |
| 692 | DNAJA2/PLXNA4 ratio | GCST90314504 | 10.81 |
| 693 | Spinal stenosis of lumbar region (PheCode 720.1) | GCST90476234 | 10.80 |
| 694 | PTPRZ1 levels | GCST90470388 | 10.79 |
| 695 | Autorefraction - 3mm cylindrical power angle (left) | Eyesight | UKBB00000064 | 10.78 |
| 696 | aparc-a2009s rh area G-pariet-inf-Angular | GCST90003395 | 10.73 |
| 697 | Retinoschisis and retinal cysts (PheCode 361.2) | GCST90475846 | 10.73 |
| 698 | COLEC12/OGN ratio | GCST90314184 | 10.73 |
| 699 | Corneal opacity and other disorders of cornea (PheCode 364) | GCST90475861 | 10.72 |
| 700 | Glaucoma | Glaucoma | UKBB00000286 | 10.68 |
| 701 | IDP dMRI TBSS MO Medial lemniscus R | GCST90003960 | 10.68 |
| 702 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 10.67 |
| 703 | Glaucoma (primary open-angle) | GCST90011766 | 10.65 |
| 704 | IDP dMRI TBSS MD Sagittal stratum L | GCST90004058 | 10.65 |
| 705 | IDP dMRI ProbtrackX MO atr r | GCST90004003 | 10.64 |
| 706 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 10.64 |
| 707 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 10.58 |
| 708 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 10.58 |
| 709 | CR2 levels | GCST90468852 | 10.56 |
| 710 | Spontaneous coronary artery dissection | GCST90245878 | 10.56 |
| 711 | ERBB3 levels | GCST90469140 | 10.55 |
| 712 | IDP dMRI ProbtrackX L3 ilf l | GCST90004314 | 10.54 |
| 713 | IDP T1 FAST ROIs L cerebellum IX | GCST90002584 | 10.53 |
| 714 | aseg global volume 4th-Ventricle | GCST90002600 | 10.52 |
| 715 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320646 | 10.49 |
| 716 | aseg global intensity WM-hypointensities | GCST90003756 | 10.48 |
| 717 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 10.47 |
| 718 | Smoking dependency | FING00001315 | 10.47 |
| 719 | GAPDH levels | GCST90469302 | 10.47 |
| 720 | PFDN5 levels | GCST90242340 | 10.42 |
| 721 | IDP dMRI ProbtrackX L1 unc l | GCST90004271 | 10.42 |
| 722 | Snoring | GCST009761 | 10.40 |
| 723 | MATN2/SCARA5 ratio | GCST90315388 | 10.36 |
| 724 | Autorefraction - 3mm weak meridian angle (left) | Eyesight | UKBB00000071 | 10.35 |
| 725 | IDP T1 FAST ROIs L front operc cortex | GCST90002531 | 10.34 |
| 726 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 10.34 |
| 727 | SERPINA3 levels | GCST90470583 | 10.34 |
| 728 | Nonalcoholic fatty liver disease | GCST90054782 | 10.34 |
| 729 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 10.33 |
| 730 | Lung cancer | GCST90011812 | 10.33 |
| 731 | Triacylglycerol_46:4_[M+NH4]1+ levels | GCST90060362 | 10.29 |
| 732 | Ascending aorta diameter | GCST90091050 | 10.27 |
| 733 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 10.26 |
| 734 | wg lh intensity-contrast superiortemporal | GCST90003821 | 10.25 |
| 735 | Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levels | GCST90317964 | 10.23 |
| 736 | Medication use (antithrombotic agents) | GCST90018762 | 10.23 |
| 737 | Hypermetropia (PheCode 367.8) | GCST90475882 | 10.23 |
| 738 | DTI autoptx MD unc l tract | GCST90385245 | 10.23 |
| 739 | aparc-Desikan rh volume parahippocampal | GCST90002816 | 10.21 |
| 740 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31) | GCST90320850 | 10.18 |
| 741 | Succinylcarnitine levels | GCST90243874 | 10.17 |
| 742 | DCBLD2 levels | GCST90468952 | 10.17 |
| 743 | Diverticular disease of intestine | FING00000471 | 10.15 |
| 744 | HMCN2 levels | GCST90469461 | 10.13 |
| 745 | NPL levels | GCST90470072 | 10.13 |
| 746 | IDP dMRI TBSS L2 Tapetum L | GCST90004170 | 10.09 |
| 747 | OLR1/PLAUR ratio | GCST90315584 | 10.09 |
| 748 | Lumbar disc prolapse | FING00000735 | 10.06 |
| 749 | ITGA11 levels | GCST90469633 | 10.06 |
| 750 | Pulmonary tuberculosis | GCST90018672 | 10.05 |
| 751 | aparc-a2009s lh area S-subparietal | GCST90003367 | 10.03 |
| 752 | Other peripheral nerve disorders | neurological | UKBB00000618 | 10.02 |
| 753 | Deep bite | FING00000380 | 10.02 |
| 754 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 43) | GCST90320606 | 10.02 |
| 755 | LRRN1 levels | GCST90469806 | 10.00 |
| 756 | aparc-a2009s rh thickness Pole-temporal | GCST90003719 | 10.00 |
| 757 | aparc-DKTatlas rh volume parahippocampal | GCST90002907 | 9.99 |
| 758 | Other disorders of eyelids (PheCode 374) | GCST90475890 | 9.98 |
| 759 | POSTN levels | GCST90470288 | 9.98 |
| 760 | CAPG levels | GCST90468537 | 9.96 |
| 761 | Heart rate variability (standard deviation of normal-to-normal intervals) | GCST90281265 | 9.95 |
| 762 | NCR1 levels | GCST90090153 | 9.94 |
| 763 | Volume of left central nucleus | GCST90474958 | 9.91 |
| 764 | PSME2/RBKS ratio | GCST90315737 | 9.91 |
| 765 | MXRA8 levels | GCST90469968 | 9.87 |
| 766 | CFB levels | GCST90240778 | 9.85 |
| 767 | Valine levels | GCST90243453 | 9.81 |
| 768 | aparc-DKTatlas lh area caudalmiddlefrontal | GCST90003236 | 9.78 |
| 769 | CR2/TNFRSF13B ratio | GCST90314225 | 9.76 |
| 770 | Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivity | GCST90302733 | 9.76 |
| 771 | Back pain | symptoms | UKBB00000084 | 9.76 |
| 772 | DTI TBSS FA Posterior corona radiata R | GCST90384406 | 9.74 |
| 773 | SCARF2 levels | GCST90470537 | 9.73 |
| 774 | Total thigh muscle volume z-score | GCST90267356 | 9.73 |
| 775 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 9.70 |
| 776 | IDP dMRI ProbtrackX MD cgh l | GCST90004225 | 9.70 |
| 777 | TMSB10/TRIAP1 ratio | GCST90315924 | 9.68 |
| 778 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 9.68 |
| 779 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 9.68 |
| 780 | CCL2 levels | GCST90012007 | 9.65 |
| 781 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 9.63 |
| 782 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 9.63 |
| 783 | Other forms of systemic lupus erythematosus | FING00001051 | 9.63 |
| 784 | DTI autoptx L2 unc l tract | GCST90385191 | 9.59 |
| 785 | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | GCST90004116 | 9.59 |
| 786 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 9.58 |
| 787 | FABP5 levels | GCST90469177 | 9.58 |
| 788 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 9.57 |
| 789 | CAG-177 sp003514385 abundance in stool | GCST90032259 | 9.57 |
| 790 | CD70 levels | GCST90468645 | 9.56 |
| 791 | wg lh intensity-contrast bankssts | GCST90003793 | 9.55 |
| 792 | Hearing aid use | GCST90044774 | 9.55 |
| 793 | DKKL1 levels | GCST90469000 | 9.52 |
| 794 | Contracture of palmar fascia [Dupuytren's disease] (PheCode 728.71) | GCST90476245 | 9.49 |
| 795 | Right-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302828 | 9.44 |
| 796 | aparc-a2009s rh volume S-collat-transv-ant | GCST90003048 | 9.44 |
| 797 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71) | GCST90320634 | 9.43 |
| 798 | aparc-Desikan lh volume parsopercularis | GCST90002785 | 9.43 |
| 799 | CLUL1 levels | GCST90468792 | 9.43 |
| 800 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 9.41 |
| 801 | COL3A1 levels | GCST90468817 | 9.41 |
| 802 | HGF/TNFSF14 ratio | GCST90315060 | 9.41 |
| 803 | Multi-trait sex score | GCST90270118 | 9.35 |
| 804 | DTI autoptx FA slf l tract | GCST90385133 | 9.35 |
| 805 | Acetate levels | GCST90092803 | 9.33 |
| 806 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 9.32 |
| 807 | Pain type(s) experienced in last month - Headache | Pain | UKBB00000627 | 9.31 |
| 808 | SCAMP3/VPS53 ratio | GCST90315807 | 9.30 |
| 809 | Hemorrhoids | circulatory system | UKBB00000325 | 9.30 |
| 810 | aparc-Desikan lh area caudalmiddlefrontal | GCST90003076 | 9.27 |
| 811 | AIFM1/PLXNA4 ratio | GCST90313220 | 9.27 |
| 812 | CAG-177 abundance in stool | GCST90032261 | 9.26 |
| 813 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40) | GCST90320859 | 9.26 |
| 814 | HJV levels | GCST90469455 | 9.25 |
| 815 | Volume of left whole amygdala | GCST90474988 | 9.19 |
| 816 | aparc-Desikan rh volume insula | GCST90002834 | 9.17 |
| 817 | CHCHD10 levels | GCST90468738 | 9.17 |
| 818 | Tibiofemoral angle | GCST90270263 | 9.16 |
| 819 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 9.16 |
| 820 | DTI TBSS L3 Anterior corona radiata R | GCST90384546 | 9.14 |
| 821 | ICD10 N97.8: Female infertility of other origin | GCST90454225 | 9.12 |
| 822 | aparc-DKTatlas lh volume caudalmiddlefrontal | GCST90002864 | 9.11 |
| 823 | DPP6 levels | GCST90469034 | 9.10 |
| 824 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 9.10 |
| 825 | aseg rh intensity Lateral-Ventricle | GCST90003778 | 9.09 |
| 826 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007527 | 9.08 |
| 827 | MAVS/PPP1R9B ratio | GCST90315393 | 9.08 |
| 828 | Spondylosis | FING00001327 | 9.07 |
| 829 | Acute appendicitis, with complications | FING00000019 | 9.03 |
| 830 | aparc-a2009s rh thickness G-cuneus | GCST90003687 | 9.03 |
| 831 | aparc-Desikan lh volume caudalmiddlefrontal | GCST90002771 | 9.03 |
| 832 | CD59/SCARB2 ratio | GCST90313859 | 9.02 |
| 833 | Triglyceride to phosphoglyceride ratio | GCST90454483 | 9.00 |
| 834 | FCRL2/SEMA7A ratio | GCST90314800 | 8.98 |
| 835 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 8.96 |
| 836 | IDP dMRI ProbtrackX OD str l | GCST90004473 | 8.95 |
| 837 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 8.94 |
| 838 | CCDC80 levels | GCST90468562 | 8.93 |
| 839 | Insomnia (weighted GWA) | GCST90267287 | 8.92 |
| 840 | Other diseases of blood and blood-forming organs, wide | FING00000999 | 8.92 |
| 841 | Dissection of aorta | FING00000467 | 8.90 |
| 842 | IDP T1 FAST ROIs V cerebellum X | GCST90002588 | 8.90 |
| 843 | ALCAM/ENPP2 ratio | GCST90313236 | 8.87 |
| 844 | Spinal stenosis | musculoskeletal | UKBB00000792 | 8.86 |
| 845 | Height (weighted GWA) | GCST90267285 | 8.86 |
| 846 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85) | GCST90320904 | 8.78 |
| 847 | CTSC/PLA2G15 ratio | GCST90314311 | 8.75 |
| 848 | Volume of left central nucleus | GCST90474883 | 8.74 |
| 849 | ADAM9 levels | GCST90468221 | 8.74 |
| 850 | BA-exvivo rh area entorhinal | GCST90003234 | 8.74 |
| 851 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 8.73 |
| 852 | Acquired foot deformities (PheCode 735) | GCST90476247 | 8.72 |
| 853 | Umbilical hernia | FING00001395 | 8.71 |
| 854 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 8.69 |
| 855 | Valine levels | GCST90132752 | 8.67 |
| 856 | Barrett's esophagus | GCST90000515 | 8.65 |
| 857 | Spherical power (left) | Autorefraction | UKBB00000790 | 8.65 |
| 858 | CCL17/CD69 ratio | GCST90313684 | 8.64 |
| 859 | X-21286 levels | GCST90200562 | 8.63 |
| 860 | IDP dMRI TBSS L2 Pontine crossing tract | GCST90004124 | 8.63 |
| 861 | CD48 levels | GCST90425676 | 8.62 |
| 862 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320891 | 8.61 |
| 863 | Frequency of heavy DIY in last 4 weeks | Physical activity | UKBB00000263 | 8.59 |
| 864 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102) | GCST90320665 | 8.56 |
| 865 | IDP dMRI TBSS MD Corticospinal tract R | GCST90004033 | 8.54 |
| 866 | DTI autoptx FA unc r tract | GCST90385138 | 8.51 |
| 867 | Tyrosine levels | GCST90243425 | 8.51 |
| 868 | CHCHD6 levels | GCST90468739 | 8.50 |
| 869 | ATXN10/SLC27A4 ratio | GCST90313399 | 8.49 |
| 870 | GPNMB levels | GCST90469393 | 8.48 |
| 871 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus L | GCST90004518 | 8.46 |
| 872 | IDP T1 FAST ROIs L planum temporale | GCST90002541 | 8.44 |
| 873 | CES1 levels | GCST90468718 | 8.44 |
| 874 | X-25371 levels | GCST90200656 | 8.43 |
| 875 | Enteritis due to Yersinia enterocolitica | FING00000505 | 8.41 |
| 876 | Operation code - varicose vein surgery | Operations | UKBB00000568 | 8.40 |
| 877 | HippSubfield rh volume subiculum-body | GCST90002691 | 8.40 |
| 878 | aparc-Desikan rh area parstriangularis | GCST90003126 | 8.40 |
| 879 | Retinal detachments and breaks | Disorders of choroid and retina | UKBB00000755 | 8.40 |
| 880 | CTSL levels | GCST90468914 | 8.39 |
| 881 | MEGF9 levels | GCST90469884 | 8.38 |
| 882 | ASGR1/GGT5 ratio | GCST90313365 | 8.35 |
| 883 | ICD10 N97.0: Female infertility associated with anovulation | GCST90454223 | 8.33 |
| 884 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15 | ECGU000015 | 8.33 |
| 885 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite level | GCST90616403 | 8.32 |
| 886 | Redundant prepuce, phimosis and paraphimosis | FING00001246 | 8.32 |
| 887 | BAMBI levels | GCST90468420 | 8.30 |
| 888 | Idiopathic gout | FING00000658 | 8.29 |
| 889 | Osteoporosis | FING00000914 | 8.28 |
| 890 | COMP levels | GCST90468827 | 8.28 |
| 891 | Retinal detachment with retinal defect | sense organs | UKBB00000754 | 8.28 |
| 892 | DTI TBSS MD Cingulum hippocampus R | GCST90384608 | 8.27 |
| 893 | aparc-Desikan rh volume precentral | GCST90002824 | 8.26 |
| 894 | Unspecified monoarthritis | musculoskeletal | UKBB00000882 | 8.26 |
| 895 | IDP dMRI ProbtrackX L2 ifo l | GCST90004285 | 8.26 |
| 896 | Endometriosis | GCST90018619 | 8.25 |
| 897 | CA11 levels | GCST90468506 | 8.24 |
| 898 | TNFRSF14/TNFSF14 ratio | GCST90315936 | 8.23 |
| 899 | NXPH3 levels | GCST90470112 | 8.22 |
| 900 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59) | GCST90320878 | 8.20 |
| 901 | FABP2/RBP2 ratio | GCST90314757 | 8.16 |
| 902 | CXCL5 levels | GCST90000461 | 8.15 |
| 903 | X-24337 levels | GCST90200629 | 8.15 |
| 904 | rfMRI connectivity ICA-features 4 | GCST90006342 | 8.15 |
| 905 | ALB levels | GCST90475103 | 8.12 |
| 906 | IDP dMRI ProbtrackX MD cst l | GCST90004227 | 8.12 |
| 907 | NCAM2 levels | GCST90470004 | 8.11 |
| 908 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 8.10 |
| 909 | ADGRE5/VCAM1 ratio | GCST90313184 | 8.10 |
| 910 | aparc-a2009s lh area S-temporal-sup | GCST90003369 | 8.09 |
| 911 | Indolelactate levels | GCST90243507 | 8.04 |
| 912 | Osteoporosis | GCST90468145 | 8.03 |
| 913 | PGR levels | GCST90470223 | 8.02 |
| 914 | AZU1/MPO ratio | GCST90313425 | 8.01 |
| 915 | Current employment status - Doing unpaid or voluntary work | Employment | UKBB00000157 | 8.00 |
| 916 | IDP dMRI TBSS OD Posterior corona radiata R | GCST90004428 | 7.99 |
| 917 | BA-exvivo rh thickness BA2 | GCST90003528 | 7.98 |
| 918 | Other menopausal disorders | FING00001071 | 7.98 |
| 919 | DTI autoptx FA fmi tract | GCST90385123 | 7.98 |
| 920 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 7.97 |
| 921 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024812 | 7.97 |
| 922 | ANGPTL2 levels | GCST90468303 | 7.97 |
| 923 | Barrett's esophagus | GCST003738 | 7.95 |
| 924 | FCRL2/LY9 ratio | GCST90314799 | 7.94 |
| 925 | MESD/NCK2 ratio | GCST90315421 | 7.93 |
| 926 | Cryptic phenotype that captures Alport syndrome severity | GCST90101828 | 7.93 |
| 927 | Fracture of lower leg, including ankle | FING00000555 | 7.93 |
| 928 | ITGBL1 levels | GCST90469648 | 7.93 |
| 929 | X-12095--N1-methyl-3-pyridone-4-carboxamide levels | GCST90243701 | 7.92 |
| 930 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 7.92 |
| 931 | ICD10 N80: Endometriosis | GCST90454213 | 7.92 |
| 932 | Atherosclerosis (PheCode 440) | GCST90475989 | 7.91 |
| 933 | IDP dMRI ProbtrackX MD fmi | GCST90004230 | 7.91 |
| 934 | GLB1/IMPA1 ratio | GCST90314932 | 7.90 |
| 935 | Benign leiomyoma with endometriosis (controls excluding all cancers) | FING00000145 | 7.90 |
| 936 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 7.88 |
| 937 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 7.85 |
| 938 | SPTLC1 levels | GCST90427130 | 7.83 |
| 939 | Forced expiratory volume (baseline) | GCST90565844 | 7.81 |
| 940 | CD55 levels | GCST90468637 | 7.79 |
| 941 | Heart valve replaced (PheCode 395.6) | GCST90475915 | 7.79 |
| 942 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320928 | 7.78 |
| 943 | CCN1/DNAJB1 ratio | GCST90313709 | 7.76 |
| 944 | Other specified and unspecified disorders of lens | FING00001101 | 7.75 |
| 945 | Facial ageing | Sun exposure | UKBB00000233 | 7.74 |
| 946 | Recent feelings or nervousness or anxiety | Anxiety | UKBB00000741 | 7.74 |
| 947 | IDP dMRI ProbtrackX MD ar r | GCST90004220 | 7.74 |
| 948 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 7.74 |
| 949 | CLK2 levels | GCST90240975 | 7.72 |
| 950 | N-acetyl-2-aminoadipate levels | GCST90200268 | 7.71 |
| 951 | VIT levels | GCST90471041 | 7.70 |
| 952 | Phosphatidylcholine acyl-alkyl C36:5 levels | GCST90240073 | 7.70 |
| 953 | LGALS3 levels | GCST90179303 | 7.67 |
| 954 | Calculus of lower urinary tract | FING00000237 | 7.67 |
| 955 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 7.66 |
| 956 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 7.65 |
| 957 | Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers) | FING00000864 | 7.65 |
| 958 | Cataract | sense organs | UKBB00000120 | 7.63 |
| 959 | TSTA3 levels | GCST90421854 | 7.63 |
| 960 | NTRK2 levels | GCST90470097 | 7.62 |
| 961 | MCEE levels | GCST90469871 | 7.62 |
| 962 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 7.60 |
| 963 | aparc-a2009s lh thickness G-precuneus | GCST90003632 | 7.59 |
| 964 | aparc-pial lh area rostralmiddlefrontal | GCST90003167 | 7.59 |
| 965 | Descending aorta strain | GCST90267389 | 7.58 |
| 966 | Sulcal opening distance of the right calloso-marginal posterior fissure | GCST90104946 | 7.57 |
| 967 | Iritis | GCST90018651 | 7.57 |
| 968 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 7.56 |
| 969 | 3-amino-2-piperidone levels | GCST90200188 | 7.55 |
| 970 | SERPING1 levels | GCST90470600 | 7.54 |
| 971 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369 | ECGU000369 | 7.54 |
| 972 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374 | ECGU000374 | 7.54 |
| 973 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320825 | 7.53 |
| 974 | APP/FKBP1B ratio | GCST90313323 | 7.53 |
| 975 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 7.53 |
| 976 | Retinal thickness (functional principal component 2) | GCST90455722 | 7.50 |
| 977 | NTPROBNP levels | GCST90470096 | 7.48 |
| 978 | Pulse pressure | GCST90018750 | 7.48 |
| 979 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 7.46 |
| 980 | Hip minimal joint space width | GCST90281365 | 7.44 |
| 981 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28 | ECGA000028 | 7.44 |
| 982 | Offspring birth weight | GCST005314 | 7.43 |
| 983 | Non-cancer illness code, self-reported - migraine | Medical conditions | UKBB00000520 | 7.42 |
| 984 | B4GALT1/SMOC2 ratio | GCST90313433 | 7.42 |
| 985 | BA-exvivo rh volume BA3b | GCST90002852 | 7.41 |
| 986 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364 | ECGU000364 | 7.39 |
| 987 | Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | UKBB00000294 | 7.37 |
| 988 | IDP T1 FAST ROIs L cerebellum VIIIb | GCST90002581 | 7.36 |
| 989 | GGCT levels | GCST90469334 | 7.36 |
| 990 | DNAJA2/HPCAL1 ratio | GCST90314503 | 7.34 |
| 991 | IDP dMRI ProbtrackX L2 atr l | GCST90004275 | 7.33 |
| 992 | NPY/SMOC1 ratio | GCST90315551 | 7.33 |
| 993 | Nonalcoholic fatty liver disease | GCST90275041 | 7.32 |
| 994 | Butyrylcarnitine levels | GCST90243589 | 7.32 |
| 995 | IDP dMRI ProbtrackX FA str r | GCST90003949 | 7.31 |
| 996 | Chronic obstructive pulmonary disease | GCST90018587 | 7.30 |
| 997 | Cataract (PheCode 366) | GCST90043785 | 7.30 |
| 998 | Knee osteoarthritis | GCST007090 | 7.29 |
| 999 | IDP dMRI TBSS L1 Corticospinal tract R | GCST90004081 | 7.29 |
| 1000 | AGRN/HSPG2 ratio | GCST90313201 | 7.28 |